The DR-TB Scale-Up Treatment Action Team (DR-TB STAT) issued a Bedaquiline Bulletin.
The purpose of the bulletin is to provide additional information and clarification on the WHO Meeting Report on bedaquiline (Report of the Guideline Development Group Meeting on the use of bedaquiline in the treatment of multidrug-resistant tuberculosis) that was released on March 13, 2017. The bulletin contains information that may be of special interest to TB programs, front-line providers, and the donor community.
To access the bulletin, click here.